Evidence map›Paper›PMID 31676784›Full record

ArticleNature communications2019

The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature.

C Peghaire, N P Dufton, M Lang, I I Salles-Crawley, J Ahnström, V Kalna, C Raimondi, C Pericleous, L Inuabasi, R Kiseleva and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Case Report: A heterozygous loss-of-function variant of theFrontiers in cardiovascular medicine · 2025
    Article
  12. EndothelialResearch square · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Endothelial mechanobiology in atherosclerosis.Cardiovascular research · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

C PeghaireNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-3304-3018
N P DuftonNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-6283-9210
M LangNational Heart and Lung Institute, Imperial College London, London, UK.
I I Salles-CrawleyCentre for Haematology, Hammersmith Hospital Campus, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-7394-0587
J AhnströmCentre for Haematology, Hammersmith Hospital Campus, Imperial College London, London, UK.
V KalnaNational Heart and Lung Institute, Imperial College London, London, UK.
C RaimondiNational Heart and Lung Institute, Imperial College London, London, UK.
C PericleousNational Heart and Lung Institute, Imperial College London, London, UK.
L InuabasiNational Heart and Lung Institute, Imperial College London, London, UK.
R KiselevaDepartment of Pharmacology, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, USA.
V R MuzykantovDepartment of Pharmacology, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, USA.
J C MasonNational Heart and Lung Institute, Imperial College London, London, UK.
G M BirdseyNational Heart and Lung Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-0981-8672
A M RandiNational Heart and Lung Institute, Imperial College London, London, UK. a.randi@imperial.ac.uk.
Imperial College London · GBHammersmith Hospital · GBTranslational Therapeutics (United States) · USLung Institute · US

Funding

TRAINING GRANT IN HEMOSTASIS AND THROMBOSIST32HL007971 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Rodney M Camire · 2001 to 2026
$10.6M
Targeting novel biotherapeutics to endotheliumR01HL128398 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUZYKANTOV, VLADIMIR R · 2015 to 2018
$2.2M
British Heart Foundation FS/12/60/29874British Heart Foundation FS/16/22/32045British Heart Foundation PG/14/90/31219British Heart Foundation PG/17/22/32868British Heart Foundation PG/17/42/33039British Heart Foundation RG/18/3/33405NHLBI NIH HHS R01 HL128398NHLBI NIH HHS T32 HL007971Versus Arthritis 21223
6 · The paper itself

Abstract

Endothelial cells actively maintain an anti-thrombotic environment; loss of this protective function may lead to thrombosis and systemic coagulopathy. The transcription factor ERG is essential to maintain endothelial homeostasis. Here, we show that inducible endothelial ERG deletion (Erg

Indexed as

Gene Expression RegulationAnimalsCells, CulturedEndothelial CellsHumansKruppel-Like Transcription FactorsMice, KnockoutMicrovesselsPromoter Regions, GeneticSignal TransductionStress, MechanicalThrombomodulinThrombosisTranscriptional Regulator ERGKlf2 protein, mouseKruppel-Like Transcription FactorsThrombomodulinTranscriptional Regulator ERG

Identifiers

PMID31676784
PMCPMC6825134
OpenAlexW2984338476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.